Sethia, S. and Squillante, E. Solid Dispersions: Revival
with greater possibilities and applications in oral drug delivery.
Critical Reviews in Therapeutic Drug Carrier Systems
Rajeswari, R.V., Lau Chem, C., and Squillante, E. “Transdermal
permeation of isradipine as liposomes, niosomes and transfersomes
through hairless mouse skin.” International Journal of
Pharmaceutics September, 2003.
Sethia, S. and Squillante, E. “Physicochemical
characterization of solid dispersions of carbamazepine and PVP K30
formulated by supercritical and conventional solvent evaporation
method.” International Journal of Pharmaceutics September,
Sethia, S. and Squillante, E. “In Vitro-In Vivo evaluation
of supercritical processed solid dispersions: permeability and
viability assessment in caco-2 cells.” Pharmaceutical
Research, 151, 2003.
Rios, E., Ashby, C. and Squillante, E. “Gamma-vinyl GABA-induced
dopamine release following cocaine challenge in the nucleus
accumbens.” Current Separations July 2003.
Rao, R.A., Sethia, S. and Squillante, E. “Crystal habit
alteration of a selective COX-2 inhibitor by supercritical carbon
dioxide processing.” Submitted to International Journal of
Pharmaceutics August 2003 KU-2092.
Rao, R.A., Sethia, S. and Squillante, E. “Preformulation studies
of supercritical carbon dioxide-processed solid dispersions of a
selective COX-2 inhibitor.” AAPS Conference on Advance in
Pharmaceutical Processing. June 19-20, 2003 Parsipanny, N.J.
(awarded “Outstanding Poster” of the meeting)
Bagchi, S. and Squillante, E. “Swelling and permeation studies
of Eudragit free films.” Submitted MS#999802 Journal of
Pharmacy & Pharmaceutical Sciences April 2003.
Mundhra, D.B., Yoburn, B. Squillante, E. “Preformulation
studies for pH controlled release of ß-galactosidase by Eudragit
L100 using supercritical carbon dioxide as the novel method of
solvent evaporation.” Submitted to International Journal of
Pharmaceutics June 2003 KU-2903.
Sethia, S. and Squillante, E. “Physicochemical characterization
of solid dispersions of carbamazepine formulated by supercritical
carbon dioxide and conventional solid evaporation method.”
Journal of Pharmaceutical Sciences 91:9 (2002)
Squillante, E. and Rios, E. “Measurement of nasal residence time
by microdialysis.” Current Separations 19:4 (2002)
Squillante, E. and Mehta, K. “Extended release chlorpheniramine
maleate from polymethacrylate solid dispersions by supercritical
fluid processing" Drug Delivery Technology 2:5 (2002)
Alavi, A. K., Mehta, K. and Squillante, E. “Formulation of
gastroprotective and enterosoluble microparticles for an acid
labile protein.” Journal of Pharmacy and Pharmaceutical
Sciences 5:3 (2002) 234-244.
Squillante, E., Morshed, G., Bagchi, S., and Mehta, K.
“Microencapsulation of beta-galactosidase with Eudragit L-100.”
Journal of Microencapsulation 20:2 (2003) 153-167.
Rajeswari, R.V., Lau Chem, C., and Squillante, E. “In vitro
evaluation of the transdermal permeation of isradipine as
liposomes, niosomes and transfersomes using hairless mouse skin.”
AAPS 2001 Annual Meeting & Exposition, Poster W4258
Alavi, A. K., Squillante, E., Bagchi, S. and Sethia, S.
“Evaluation of supercritical carbon dioxide as a substitute for
conventional solvents in solvent evaporation process for
microencapsulation of acid labile proteins.” AAPS 2001 Annual
Meeting & Exposition, October 20, 2001. Poster 2302
Sethia, S. and Squillante, E. “Bioavailability of carbamazepine
from self-emulsifying solid dispersions formulated by supercritical
fluid technology.” AAPS 2001 Annual Meeting & Exposition,
October 20, 2001. Poster W4190
Morshed, G., Squillante, E., and Bagchi, S. “Microencapsulation
of ß-galactosidase with Eüdragit L-100.” AAPS 2001 Annual Meeting
& Exposition, October 20, 2001. Poster W4543
Metropolitan American Association for Laboratory Animal Science,
Metro AALAS Guest Speaker “Microdialysis as a Means to
Measure CNS Response in Rats.” March 8, 2001 SUNY, Stoneybrook,
Squillante, E., Needham, T. E., Zia, H. "Transdermal Delivery of
Calcium Channel Blockers, such as Nifedipine." U.S. Patent #
6,106,856 August 22, 2000.
Challa, R. V., Lau-Cam, C. A., Shahriyar, S. and Squillante, E.
“Preparation and characterization of liposomal, niosomal and
transfersomal formulations of isradipine.” AAPS: 2000 Annual
Meeting & Exposition November 1, Poster 3382.
Rajeswari, R.V., Lau Chem, C., and Squillante, E. “Comparison of
the in vitro permeation of liposomal and nonliposomal formulations
of isradipine through hairless mouse skin.” AAPS: 2000 Annual
Meeting & Exposition November 1, Poster 3378
Alavi A.K., Squillante E., and Bagchi S. “The preservative
action of polymers on the activity of lactase enzyme treated with
supercritical carbon dioxide.” AAPS Annual Meeting, November 14-18,
1999 Poster 2210.
Squillante E. and Neduvelil S. “Preparation of sustained-release
powders using supercritical fluid processing technology.” AAPS
Annual Meeting, November 14-18, 1999 Poster 3617.
Vemavarapu C., Needham T.E., Squillante E. and Zia H.
“Mechanistic evaluation of the treatment of topical hydrofluoric
acid burns using a calcium gluconate gel.” AAPS Annual Meeting,
November 14-18, 1999 Poster 1005.
Samuel K.B., Chaurasia C.S. and Squillante, E. “Effects of
non-steroidal estrogenic agent Tamoxifen on brain cholinergic and
dopaminergic systems: an on-line in vivo microdialysis
investigation.” Proceedings of the 8th International
Conference on In Vivo Methods: Monitoring Molecules in
Neuroscience. June 19-23, 1999 Stony Brook, NY. pages 287-8.
Zia, H., Rashed, S.F., Quadir, M. Needham, T.E.,
Squillante, E. "Ketorolac tromethamine and ketoprofen
suppositories release profiles and bioavailability from cocoa
butter base formulations in rabbits." International Journal of
Pharmaceutical Compounding 2 (1998) 390-393.
Squillante, E., Needham, T. E., Zia, H. “Transdermal delivery of
calcium channel blockers.” Eur. Pat. Appl. 0680759A1; Notice for
allowances: June 10, 1998.
Squillante, E., Needham, T. E., Zia, H. “Solubility and in
vitro transdermal permeation of nifedipine.” International
Journal of Pharmaceutics 159 171-180 (1997).
Squillante, E., "Evanescent wave optical fiber spectroscopy in
drug delivery." Drug Development and Industrial Pharmacy 24
Squillante, E., Nanda, A., Needham, T. E., Zia, H. “Optimization of
in vitro nifedipine penetration enhancement through hairless mouse
skin.” International Journal of Pharmaceutics 169:2
Squillante, E., Maniar, A., Kislalioglu, S., Needham, T. E.,
Zia, H. “Codiffusion of propylene glycol and dimethyl isosorbide in
hairless mouse skin.” European Journal of Pharmaceutics and
Biopharmaceutics 46:3 265-271 (1998).
Squillante, E., Needham, T.E. “Interspecies differences in
transdermal delivery of cosolvent permeation enhancers.” Controlled
Release Society Annual Meeting Las Vegas, NV 1998 (awarded ten-best
Ahmed, A.N., El-Gizawy, S.M., Squillante, E., Zia, H.,
Needham, T.E. “Effect of cyclodextrins and ß-cyclodextrin
derivatives on the solubility and skin penetration of nifedipine.”
Journal of Pharmaceutical Sciences (submitted).
Dua, R., Duncan, M., Squillante, E., Zia, H., Needham, T.E. “The
influence of the enhancer, dimyristoylphosphatidylglycerol and
formulation factors on the nasal absorption of salmon
calcitonin.” Drug Delivery March (1997).
Maniar, A., Squillante, E., Kislalioglu, S., Needham, T. E.,
Zia, H. “Optimization of solution formulations for nifedipine
across hairless mouse skin.” Pharmaceutical Development and
Technology (submitted MS# PDT 98-012).
Ko, Kuang-Ta, Squillante, E., Needham, T.E., Zia, H., Emulsion
formulations of testosterone for nasal administration. J.
Microencap., (1998) 15(2), 197-205.
Squillante, E., Needham, T.E., Zia, H. “Solubility parameter as
a predictive tool in transdermal design.” 19th Symposium
of the Controlled Release Society 495-496, 1992.
Squillante, E. “Innovative Drug Delivery Systems.” Glaxo
Wellcome Continuing Education Series. Rhode Island Society of
Hospital Pharmacists, Fall 1996.
“Career Options: Institutional Practice.” College of Pharmacy
Centennial Scholars Recognition Day. University of Rhode
Squillante, E., Rhodes, C.T., Falk, R.W. “Estimation of
Nonlinear Elimination Kinetics: Assessment of Various Methods.”
presented at Vicks Research Center, Richardson-Vicks Inc., Shelton,